Leiden Dworak - Chief Accounting Officer at TScan Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Accounting Officer
Stock Symbol
TCRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Leiden Dworak since 12/22/2023

Holdings reported by Leiden Dworak for TScan Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Voting Common Stock 5.69K $28.3K $4.97 Jul 21, 2023 Direct
Stock Option (Right to Buy) 25K Jul 21, 2023 Direct Voting Common Stock

Transactions reported by Leiden Dworak for TScan Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.